John C. Roche - 28 Feb 2022 Form 4 Insider Report for HANOVER INSURANCE GROUP, INC. (THG)

Reporting relationship: President and CEO, Director
Issuer ticker: THG
Reported as of: 28 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Mar 2022, 15:05:06 UTC
Prior SEC filing: 04 Jan 2022
Next SEC filing: 09 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Matthew R. Frascella pursuant to Confirming Statement

Key filing fact

John C. Roche filed Form 4 for HANOVER INSURANCE GROUP, INC. (THG) on 02 Mar 2022.

Key facts

This page summarizes John C. Roche's Form 4 filing for HANOVER INSURANCE GROUP, INC. (THG).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Mar 2022, 15:05.

Change

Previous filing in this sequence was filed on 04 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

THG transaction

Common Stock

Award

Transaction value: $0
Shares: +8,685
Change %: +14%
Price: $0.000000
Shares after: 70,338
Date: 28 Feb 2022
Ownership: Direct
Footnotes: F1

THG transaction

Common Stock

Award

Transaction value: $0
Shares: +4,865
Change %: +6.9%
Price: $0.000000
Shares after: 75,203
Date: 28 Feb 2022
Ownership: Direct
Footnotes: F2

THG transaction

Common Stock

Award

Transaction value: $0
Shares: +7,097
Change %: +9.4%
Price: $0.000000
Shares after: 82,300
Date: 28 Feb 2022
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THG transaction Derivative

Common Stock Option (right to buy)

Award

Transaction value: $0
Shares: +34,689
Change %
Price: $0.000000
Shares after: 34,689
Date: 28 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 34,689
Exercise price: $139.51
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On March 5, 2019, the Reporting Person was granted 5,446 (target) performance-based restricted stock units ("PBRSUs") pursuant to the Issuer's 2014 Long-Term Incentive Plan. These PBRSUs were subject to a performance-based vesting condition related to three-year average adjusted return on equity and a time-based vesting condition and also provided for the accumulation of dividend equivalent rights. On February 28, 2022, the performance condition for this award was certified at 146.4% of the target award (as adjusted for accumulated dividend equivalent rights) for the number of shares indicated. This award remains subject to the time-based vesting condition and is scheduled to vest on March 7, 2022.

Footnote F2

On March 5, 2019, the Reporting Person was granted 4,872 (target) PBRSUs pursuant to the Issuer's 2014 Long-Term Incentive Plan. These PBRSUs were subject to a performance-based vesting condition related to three-year relative total shareholder return and a time-based vesting condition and also provided for the accumulation of dividend equivalent rights. On February 28, 2022, the performance condition for this award was certified at 91.67% of the target award (as adjusted for accumulated dividend equivalent rights) for the number of shares indicated. This award remains subject to the time-based vesting condition and is scheduled to vest on March 7, 2022.

Footnote F3

Grant of restricted stock units under the Issuer's 2014 Long-Term Incentive Plan. Such units vest on the third anniversary of the date of grant.

Footnote F4

Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.